Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.


Brain Cancer

Brain cancer also referred to as brain tumors or malignant neoplasm of the brain, is a highly intricate and devastating condition that afflicts a substantial population worldwide. With an unwavering commitment to research and advancement, our company endeavors to make significant contributions to the development of novel therapies and spearhead the progress in brain cancer drug discovery.

Overview of Brain Cancer

Brain cancer refers to the abnormal growth of cells within the brain. These cells multiply uncontrollably, forming a mass or tumor that can interfere with normal brain function. Brain cancer can be classified into two main categories: primary brain cancer, which originates in the brain, and secondary brain cancer, which results from the spread of cancer cells from other parts of the body to the brain.

Pathogenesis of Brain Cancer

The pathogenesis of brain cancer involves the disruption of normal cellular processes, leading to uncontrolled cell growth and tumor formation. Genetic mutations play a crucial role in this process, affecting genes responsible for cell cycle regulation, DNA repair mechanisms, and cell differentiation. These alterations contribute to the escape of cancer cells from normal growth control, allowing them to proliferate and invade surrounding brain tissue.

Workup of a case with AHA.Fig.1 Workup of a case with AHA. (Tandel, Gopal S., et al., 2019)

Therapeutics Development of Brain Cancer

  • Targets of Brain Cancer Therapy Development
    Developing effective therapies for brain cancer requires a deep understanding of the molecular and cellular mechanisms driving tumor growth. These targets include specific genetic mutations, signaling pathways, and proteins in tumor growth and survival. One of the key genes associated with brain cancer is MIR142 (MicroRNA 142). It regulates various cellular processes and can contribute to the abnormal growth and proliferation of cancer cells. The pathways and super pathways related to MIR142 in the context of brain cancer include ERK signaling and signal transduction.
  • Types of Brain Cancer Therapy Development

    Targeted Therapy Development

    Targeted therapies, a captivating avenue in the battle against brain cancer! They have emerged as a promising approach, indeed. These therapies direct their attention towards specific genetic mutations, signaling pathways, or proteins that are distinct to cancer cells. This precision allows for a more focused and effective therapy strategy. By honing in on these specific molecular abnormalities, targeted therapies can selectively eradicate cancer cells while preserving the precious healthy brain tissue.

    Immunotherapy Development

    Immunotherapy is a groundbreaking approach to cancer therapy, utilizing the body's own immune system to identify and combat those pesky cancer cells.This innovative strategy has demonstrated remarkable success in diverse types of cancer, even in the challenging realm of brain cancer. By utilizing drugs that hinder the function of proteins responsible for suppressing the immune response, the body's immune cells can more effectively recognize and eliminate cancer cells.

  • Challenges of Brain Cancer Therapy Development
    Despite significant advancements in brain cancer therapy development, several challenges persist. The blood-brain barrier, a protective mechanism that limits the entry of substances into the brain, poses a significant hurdle in delivering therapeutic agents effectively. Additionally, the heterogeneity of brain tumors and their ability to adapt and develop resistance to therapy further complicate therapy development.
    Through innovative approaches such as nanotechnology-based carriers, receptor-mediated transport systems, and focused ultrasound technology, researchers are making significant strides in improving drug delivery to brain tumors and increasing therapeutic success.

Our Services

Our company is committed to providing comprehensive services in the field of brain cancer research and therapy development. We offer a wide range of services, including diagnostic development and therapy development. Our team of highly skilled researchers and scientists work tirelessly to advance knowledge and improve outcomes in the fight against brain cancer.

Our brain cancer disease study types:

Our brain cancer disease study types:

At our company, we understand the critical role animal models play in advancing brain cancer research. We offer state-of-the-art animal model development services tailored specifically for brain cancer studies, including pharmacokinetics studies and drug safety evaluation. Our expert team utilizes cutting-edge techniques to develop accurate and relevant animal models that mimic the characteristics of human brain tumors. If you are interested in our services, please feel free to contact us for more details and quotation information of related services.


  • Tandel, Gopal S., et al. "A review on a deep learning perspective in brain cancer classification." Cancers 11.1 (2019): 111.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Related Disease Solutions

Copyright © Protheragen. All rights reserves.